Cargando…
Design of Montelukast Nanocrystalline Suspension for Parenteral Prolonged Delivery
BACKGROUND: Montelukast (MTK), a representative leukotriene receptor antagonist, is currently being investigated as a potential candidate for treating Alzheimer’s disease. For potent and effective dosing in elderly patients, a parenteral prolonged delivery system is favored, with improved medication...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423109/ https://www.ncbi.nlm.nih.gov/pubmed/36046838 http://dx.doi.org/10.2147/IJN.S375888 |